ELISA / EIA / RIA Kits · ELISA / EIA kit · Cat. EKE-069-04
Cholecystokinin (CCK) (26-33), non-sulfated (Human, Rat, Mouse) – Extraction-Free EIA Kit
Supplied as 96 wells per unit. Species: Human, Mouse, Rat. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | EKE-069-04 |
|---|---|
| Product type | ELISA / EIA / RIA Kits · ELISA / EIA kit |
| Peptide family | Cholecystokinin (CCK) |
| Species | Human, Mouse, Rat |
| Unit size | 96 wells |
| Sensitivity | 0.04 ng/ml |
| Specificity | Peptide % CCK (26-33) (Non-Sulfated) (Human, Rat, Mouse) 100 CCK (26-33) (Sulfated) (Human, Rat, Mouse, Canine) 100 CCK (27-33) (Human, Rat, Mouse) 100 CCK-33 (Human) 100 Big Gastrin-1 (Human) 100 Gastrin-1 (Human) 100 Caerulein 100 CCK (30-33) (Human, Rat, Mouse) 43 CCK (1-21) (Human) 0 Pancreatic Polypeptide (Human) 0 VIP (Human, Rat, Mouse, Porcine, Ovine) 0 |
| Linear Range | 0.04 - 0.45 ng/ml |
| Inter-Assay CV | <15% |
| Intra-Assay CV | <10% |
| Standard Curve | Contact us for technical specifications on this product. The amount and types of fatty acids acutely affect insulin, glycemic and gastrointestinal peptide responses but not satiety in metabolic syndrome subjects. Chang CY, Kanthimathi MS, Tan AT, Nesaretnam K, Teng KT. Eur J Nutr. 2016;Epub ahead of print. An enriched, cereal-based bread affects appetite ratings and glycemic, insulinemic, and gastrointestinal hormone responses in healthy adults in a randomized, controlled trial. Gonzalez-anton C, Lopez-millan B, Rico MC, et al. J Nutr. 2015;145(2):231-8. Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity. Siejka A, Jankiewicz-wika J, St?pie? H, Fryczak J, ?wi?tos?awski J, Komorowski J. Endocrine. 2015;49(3):859-62. Reduced CCK signaling in obese-prone rats fed a high fat diet. Duca FA, Zhong L, Covasa M. Horm Behav. 2013;64(5):812-7. Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY. Flannery BM, Clark ES, Pestka JJ. Toxicol Sci. 2012;130(2):289-97. |
| Sample Extraction | Not required |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Frequently asked
What is Cholecystokinin (CCK) (26-33), non-sulfated (Human, Rat, Mouse) – Extraction-Free EIA Kit?
What is the intended use of EKE-069-04?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.